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Abstract: 
Nowadays, pharmaceutical production processes are undergoing major changes, and there is a clear 
trend towards increased use of continuous production processes [1]. The focus of our ongoing work 
is on the formulation of the Active Pharmaceutical Ingredients (APIs) into final drug products. The 
evolution from batch to continuous production is also of increasing interest in formulation 
operations [2-3]. Whereas in traditional batch processes product quality evaluation mostly relies on 
off-line, time-consuming and, hence, less efficient laboratory testing [4], the continuous approach 
possesses clear advantages as the efficiency can be improved by relying on in-line measurements and 
real-time adjustment of sensitive process variables. Monitoring and controlling the process during 
operation can be much more economical through significant decreases in product loss [4-5]. By using 
the on-line monitoring to support the implementation of real-time release in the production of 
pharmaceutics, pharmaceutical companies does not have to wait anymore till the product is 
approved by the quality lab. 
The ConsiGmaTM (ColletteTM, GEA Pharma Systems, Wommelgem, Belgium) is a continuous from-
powder-to-tablet manufacturing line intended for tablet production. The continuous line consists of 
three parts: a continuous twin screw granulator (high shear), followed by a six-segmented fluidized 
bed dryer system and a discharge system prior to the tabletting press. During continuous operation a 
large number of process variables are continuously logged. These variables can be used by the 
operator to verify smooth process behavior. However, they can be analysed in more detail as well, in 
order to improve process operation. In this contribution, a mass and energy balance verification over 
the fluidized bed dryer unit is performed, which provides further insight in the process.  
The mass balance can be used to calculate the moisture content at the end of the drying process. As 
such, by making a mass balance a time-consuming off-line Karl Fisher titration could be avoided or 
done on a less regular basis. The mass balance is based on the changing properties of the drying air 
passing the dryer unit from inlet to outlet and accounts for the evaporation process. The energy 
balance is interesting for two reasons; it can be used to compare the measured gas outlet 
temperature with the calculated value based on logged variables. A good match between prediction 
and measurement will increase trust in the correctness of the mass balance, and demonstrates 
process understanding. On the other hand the energy balance can be helpful to predict the gas 
temperature in different horizontal sections of the drying system. This information is useful to 
combine in a later stage with information about the trajectory of granules through the system. The 
fluidization behavior is investigated in another part of the project using Computational Fluid 
Dynamics (CFD). The CFD-model can give information about the bed height of the fluidized bed; 
evaporation of water only takes place in this part of the dryer, which is the most determining factor 
for the gas temperature. The temperature profile will be based on several model assumptions, which 
is acceptable since experimental measurements are time-consuming and laborious. 
Experimental data revealed that a calibration was needed in order to calculate the evaporation rate 
as a consistent offset between prediction and measurement occurred. A linear regression was 
implemented in the model to quantify this offset. A linear error propagation of measurement errors 
was pursued to account for their effect on output uncertainty.  
Based on several datasets, it can be concluded that it is indeed possible to use the standard logged 
measurements to monitor the process. As such, an important conclusion is that expensive probes 
(e.g. NIR [6]) are not always needed to implement in the final production system. However, they are 
still extremely useful in process development to support development of detailed process 
knowledge. 
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